-
1 Comment
BIOREM Inc is currently in a long term downtrend where the price is trading 9.5% below its 200 day moving average.
From a valuation standpoint, the stock is 96.2% cheaper than other stocks from the Industrials sector with a price to sales ratio of 1.2.
BIOREM Inc's total revenue sank by 18.0% to $4M since the same quarter in the previous year.
Its net income has increased by 107.3% to $155K since the same quarter in the previous year.
Finally, its free cash flow fell by 126.5% to $-142K since the same quarter in the previous year.
Based on the above factors, BIOREM Inc gets an overall score of 2/5.
Sector | Industrials |
---|---|
Industry | Pollution & Treatment Controls |
Exchange | V |
CurrencyCode | CAD |
ISIN | CA09068G1046 |
Beta | 0.76 |
---|---|
Market Cap | 35M |
PE Ratio | 15.64 |
Target Price | 4 |
Dividend Yield | None |
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It also sells biofiltration media products under the BIOSORBENS, XLD, BIOPAK, BIOROLL, and BIOBLOK names. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BRM.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025